|
|
 |
|
Viewing report
|
|
|
|
Premium Company Profile: Neurocrine Biosciences Inc
Datamonitor, Nov 2007, Pages: 53
Introduction
Neurocrine Biosciences, a neuroscience company, focuses on the discovery and development of therapeutics for the treatment of neurological and endocrine-related diseases and disorders. Neurocrine Biosciencess lead candidate Indiplon is one of the most comprehensive clinical programs for treating insomnia.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
Neurocrine Biosciences is experienced in discovering and developing therapeutics for autoimmune and inflammation, cardiovascular and circulatory system, central nervous system and endocrinology. It has in-house and collaborative pipeline products and Indiplon is its lead candidate for insomnia. The company derives its revenues from contract, licensing and collaboration. License and collaborative fees include upfront and milestone payments. During 2002-2006, the companys total revenue growth was at a CAGR of 21%. The only revenues are from licensing and collaboration During the forecast period 2006-2010, licensing, collaboration and other revenues are forecasted to grow from $18 million to $39 million. Indiplon is expected to be the main growth driver of revenues for Neurocrine Biosciences, generating sales growth of +$83 million during the period 2006-2010.
Reasons to Purchase
Access all the important information and analysis on the company in a single report Understand companys strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to companys adjusted five year financial data along with key ratios and market capitalization
Customers who bought this item also bought
Neurocrine Biosciences, Inc. - Financial and Strategic Analysis Review
Neurocrine Biosciences Inc
Indiplon Update Call - Neurocrine Biosciences, Inc. - Earnings Transcript
Kosan Biosciences, Inc:Premium Company Profile
Martek Biosciences Corp: Premium Company Profile
Neurocrine Biosciences Inc-Therapeutic Competitors
Sangamo BioSciences, Inc. - Financial and Strategic Analysis Review
Martek Biosciences Corporation - Financial and Strategic Analysis Review
Ardea Biosciences, Inc. - Financial and Strategic Analysis Review
Hana Biosciences, Inc. - Financial and Strategic Analysis Review
Aastrom Biosciences, Inc. - Financial and Strategic Analysis Review
IR Biosciences Holdings, Inc. - Financial and Strategic Analysis Review
|
|
|
|
